Best Practice & Research Clinical Haematology
Volume 24, Issue 4 , Pages 505-508, December 2011

Flow cytometry in the post fluorescence era

  • Garry P. Nolan, PhD (Professor)

      Affiliations

    • Corresponding Author InformationTel.: +1 650 725 7002; Fax: +1 650 723 2383.

Stanford University School of Medicine, 269 Campus Drive, Stanford, CA 94305, USA

While flow cytometry once enabled researchers to examine 10–-15 cell surface parameters, new mass flow cytometry technology enables interrogation of up to 45 parameters on a single cell. This new technology has increased understanding of cell expression and how cells differentiate during hematopoiesis. Using this information, knowledge of leukemia cell biology has also increased. Other new technologies, such as SPADE analysis and single cell network profiling (SCNP), are enabling researchers to put different cancers into more biologically similar categories and have the potential to enable more personalized medicine.

Keywords: flow cytometry, mass cytometry, acute leukemia, acute lymphocytic leukemia, ALL, acute myeloid leukemia, AML, hematopoiesis, SPADE, SCNP, single cell network profiling

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6926(11)00085-5

doi:10.1016/j.beha.2011.09.005

Best Practice & Research Clinical Haematology
Volume 24, Issue 4 , Pages 505-508, December 2011